Enanta Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-70.0M | $-70.7M | $750.0K | $21.0M |
| FY2022 | $-84.8M | $-86.9M | $2.1M | $27.0M |
| FY2023 | $-103.2M | $-112.2M | $9.1M | $28.2M |
| FY2024 | $-78.8M | $-96.7M | $17.9M | $26.8M |
| FY2025 | $-19.3M | $-32.2M | $12.9M | $18.6M |